US/UK/Canada

Share

Contacts

  • Stille
    Sundbybergsvägen 1A 171 73 SOLNA
    +46 (0)8-588 580 00
    +46 (0)8-588 580 05
    http://www.stille.se
    • Pick a time period -
    Tags ( Active)

    Stille AB: Year-End Report 2023

    Stille AB (publ) today presents the report for the fourth quarter and full fiscal year 2023. ”Strong finish to the year with solid sales growth, enhanced profitability and the strategic acquisition of Fehling Instruments”, summarizes President and CEO Torbjörn Sköld in the year-end report.Revenue increased in the fourth quarter by 25.0 percent to 77.3 MSEK (61.8) with strong growth from both business units. “I am pleased to note that our growth momentum remains strong in the fourth quarter, and we continue to deliver on our growth strategy. 2023 marked a significant milestone for Stille.”,

    Stille completes the acquisition of Fehling Instruments

    Stille AB (publ) has successfully completed the previously announced acquisition of the German instrument provider Fehling (Fehling Instruments GmbH & Co. KG, Fehling Verwaltungs GmbH, and associated subsidiaries, collectively referred to as "Fehling"). All conditions for the transaction and acquisition have now been met. As previously communicated, Stille has paid 36 million euros in cash upon the completion of the acquisition on a debt-free and cash-free basis. The acquisition is financed through the previously announced targeted issuance of SEK 425 million. Fehling develops and sells

    Report from the extraordinary general meeting of Stille AB on December 29, 2023

    Stille AB held an extraordinary general meeting on Friday, December 29, 2023. The main resolutions passed at the meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the extraordinary general meeting and the complete proposals, which are available on the company’s website, www.stille.se.Resolution on the number of board members, election of a board member and resolution on board remuneration The meeting resolved, in accordance with the shareholder Linc AB’s proposal, that the board of directors shall consist

    Notice of extraordinary general meeting in Stille

    The board of directors of Stille AB has resolved to convene an extraordinary general meeting to be held on Friday, December 29, 2023. More detailed information about the contents of the proposals may be obtained from the complete notice to the extraordinary general meeting below. The notice will be published in the Swedish Official Gazette (Sw. Post- och Inrikes Tidningar) and on the company’s website within the next few days.NOTICE OF EXTRAORDINARY GENERAL MEETING OF STILLE AB Stille AB holds an extraordinary general meeting on Friday, December 29, 2023 at 09:00 am at the company’s

    Stille carries out a directed share issue of approximately SEK 425 million

    NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. The board of directors of Stille AB (publ) (“Stille” or the “Company”) has resolved to issue 3,971,963 new shares at a subscription

    Stille has entered into an agreement to acquire Fehling Instruments

    Stille AB (publ) (“Stille” or the “Company”) has entered into an agreement to acquire all shares outstanding of Fehling Instruments GmbH & Co. KG and Fehling Verwaltungs GmbH (jointly “Fehling”) for a consideration of EUR 36 million (approximately SEK 410 million) on a cash- and debt-free basis. The acquisition is conditional upon the Company receiving sufficient financing to carry out the acquisition and the Company's board of directors thus intends to resolve on a directed issue of shares subject to the general meeting's subsequent approval. Through the acquisition, Stille significantly

    Stille AB: Interim Report Q3 2023

    Stille AB (publ) publishes the report for the third quarter of the business year 2023. ”Strong sales growth, profitability and cashflow in the third quarter”, summarizes President and CEO Torbjörn Sköld.Revenue increased in the third quarter by 17.7 percent to 70.1 MSEK (59.6) after strong growth from both business units. “I am pleased to see that our strong growth compared to previous year continued in the third quarter”, comments Torbjörn Sköld. The gross profit amounted to 46.7 percent (45.1). Business unit Surgical Tables was affected by an unfavorable product and market mix, while

    Notice of Extraordinary General Meeting in Stille AB

    The shareholders in Stille AB, Reg. No. 556249-4848, are invited to the Extraordinary General Meeting to be held on Friday 22 September 2023 at 11:00 at Eskilstunavägen 34, SE-644 30 Torshälla.The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Right to participate and notification Shareholders wishing to attend the General Meeting must: · partly be registered in the company’s share register kept by Euroclear Sweden AB as of Thursday 14 September 2023; · partly notify

    Stille AB: Interim Report Q2 2023

    Stille AB (publ) publishes the report for the second quarter and first half of the business year 2023. ”Strong sales growth, profitability and cashflow in the second quarter”, summarizes President and CEO Torbjörn Sköld.Revenue increased in the second quarter by 18.6 percent to 75.1 MSEK (63.3) after strong growth from both business units. “I am pleased to see the continued strong growth compared to previous year given that the first half year last year was a record period”, comments Torbjörn Sköld. The gross profit amounted to 44.6 percent (45.4). Business unit Surgical Tables was

    Stille AB: Interim Report Q1 2023

    Stille AB (publ) publishes the report for the first quarter of the business year 2023. ”Good start – strong sales growth and significantly improved operating cashflow”, summarizes President and CEO Torbjörn Sköld.Revenues increased in the first quarter by 17.5 percent to 72.4 (61.6) after strong growth from both business units. “I am satisfied to see such strong growth compared to previous year given that the first quarter last year was a record quarter”, comments Torbjörn Sköld. The gross profit amounted to 42.4 percent (44.8). Business unit Surgical Tables was affected by an

    Notice of Annual General Meeting

    Stille AB (publ) herby gives notice to attend the Annual General Meeting at Eskilstunavägen 34, 644 30, Torshälla, on May 5th, 2023, at 13.00.Right to Participate To participate in the Annual General Meeting, one must be recorded as shareholder in the share register maintained by Euroclear Sweden AB on April 26th, 2023, and no later than April 28th, 2023, at 12.00, to register their participation in the Annual General Meeting to the company. Shareholders who have their shares registered in the name of a nominee must request the nominee to enter the shareholder into the share register.

    Stille AB: Year-End Report 2022

    Stille AB (publ) publishes the year-end report for 2022. ”Solid growth and strong profit deveopment.”, summarizes Niklas Carlén, Stille’s interim CEO.Revenues increased in the fourth quarter by four percent to 61.8 (59.6) and EBIT increased by 60 percent to 8.8 MSEK (5.5). Profitability was positively affected by currency effects. For the full year 2022, sales grew by 76 percent, out of which 16 percent in organic growth. Operating profit increased to 32.4 MSEK (20.1). In the fourth quarter, business unit Surgical Table sales declined by four percent following significant component

    Torbjörn Sköld Appointed New CEO of Stille AB

    Stille AB (publ) announces the board of director’s decision to appoint Torbjörn Sköld as the new CEO of Stille AB. Torbjörn Sköld has long experience from leading positions where the last 20 years have been within Life science with a primary focus on orthopedics and neurosurgery. The board of directors sees Torbjörns background and experience as great value, and he is well-suited to further enhance Stille’s strategy and increase shareholder value.Torbjörn will begin his tenure on March 20th, 2023, where he will replace Hanna Ernestam Wilkman who has been the company’s CEO since April 1st,

    Stille AB: Interim Report Q3 2022

    Stille AB (publ) publishes the interim report for the third quarter of 2022. ”The first three quarters of this year has displayed significant growth coupled with solid profitability. The third quarter continued the positive trend achieved during previous quarters this year”, says Hanna Ernestam Wilkman, Stille’s CEO.Revenues increased by 17 percent to 59.6 MSEK (51.1). Operating profit increased by 32 percent to 7.2 MSEK (5.5). Positive currency effects of 2.7 MSEK affected the result after financial items. Revenues for Surgical Instruments increased by six percent to 30.1 MSEK (28.4).

    Stille AB: Interim Report Q2 2022

    Stille AB (publ) publishes the interim report for the second quarter and first half-year of 2022. ”Strong growth and significantly improved profits.”, summarizes Hanna Ernestam Wilkman, Stille’s CEO.Revenues increased by 56 percent to 63.3 MSEK (40.6) and the organic growth amounted to 14 percent with revenues of 46.1 MSEK. Operating profit increased by 72 percent 8.9 MSEK (5.2). Compared to the same quarter last year, business unit Surgical Instruments doubled its revenue driven by the acquired volume of S&T. For the same period, business unit Surgical Tables increased sales by 25

    Stille AB: Interim Report Q1 2022

    Stille AB (publ) publishes the report for the first quarter of 2022. ”A record breaking first quarter coupled with a high profitability.”, summarizes Stille CEO Hanna Ernestam Wilkman.Revenues for the first quarter increased by 72 percent to 61.6 MSEK (35.8) and the organic growth amounted to 21 percent with revenues of 43.3 MSEK. Operating profit increased to 7.5 MSEK (4.0). ”I can conclude that revenues for business unit Surgical Tables never has been higher than during the first quarter 2022. Most notable is the growth outside the US where sales increased by 52 percent compared to the

    Stille AB: Year-End Report 2021

    Stille AB (publ) publishes the report for the fourth quarter and the full year of 2021. ”Strong sales despite current market situation”, summarizes Stille CEO Hanna Ernestam Wilkman.Revenues for the fourth quarter reached 59.6 MSEK (45.0), including recently acquired S&T whose sales exceeded expectations. Excluding the acquisition sales amounted to 44.0 MSEK despite challenges in the US for both business units.  ”To strengthen growth in the US-market, we have in December launched a new general surgery table, GS2®, in an exclusive collaboration with GE Healthcare, and signed an exclusive

    Stille Signs Exclusive Distribution Agreement for Surgical Instruments in US

    Stille AB (publ) announces the appointment of Synovis Micro Companies Alliance, Inc,. as its exclusive distributor of surgical instruments in the United States.With over 20 years of experience in the market, Synovis Micro Companies Alliance, Inc, a Baxter-owned company, has successfully targeted surgical disciplines that require the finest surgical instrumentation, including the microsurgical, plastics and cardiovascular disciplines. As of January 1st, 2022, Synovis has been appointed the exclusive distributor of Stille’s surgical instruments in the United States. “This is a major step

    Stille AB: Interim Report Q3 2021

    Stille AB (publ) publishes the report for the third quarter. “A quarter with strong growth”, summarizes CEO Hanna Ernestam Wilkman.Stille delivered growth both organically as well as through the acquisition of Swiss company S&T AG. Organic sales grew by 12% compared to the same quarter previous year. “The acquisition of S&T means that business unit Surgical Instruments has doubled in size. The integration of the company is progressing according to plan. Our main focus is to realize identified cross-selling synergies within both product and distribution network”, says CEO Hanna Ernestam

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe